Chronic opioid use in IBD tied to biologic discontinuation
Inflammatory bowel disease (IBD) patients with chronic opioid use are highly likely to discontinue their biologic therapy, according to a study. Furthermore, opioid withdrawal symptoms mimic IBD flares, leading to inappropriate switching of biologics and compromising disease control.
